PatientsVille.com Logo

Depressed and Lorazepam

PatientsVille

Depressed Symptoms and Causes

What is insomnia?

Insomnia is a common sleep disorder. If you have it, you may have trouble falling asleep, staying asleep, or both. As a result, you may get too little sleep or have poor-quality sleep. You may not feel refreshed when you wake up.

What are the symptoms of insomnia?

Symptoms of insomnia include:

  • Lying awake for a long time before you fall asleep
  • Sleeping for only short periods
  • Being awake for much of the night
  • Feeling as if you haven't slept at all
  • Waking up too early
What are the types of insomnia?

Insomnia can be acute (short-term) or chronic (ongoing). Acute insomnia is common. Common causes include stress at work, family pressures, or a traumatic event. It usually lasts for days or weeks.

Chronic insomnia lasts for a month or longer. Most cases of chronic insomnia are secondary. This means they are the symptom or side effect of some other problem, such as certain medical conditions, medicines, and other sleep disorders. Substances such as caffeine, tobacco, and alcohol can also be a cause.

Sometimes chronic insomnia is the primary problem. This means that it is not caused by something else. Its cause is not well understood, but long-lasting stress, emotional upset, travel and shift work can be factors. Primary insomnia usually lasts more than one month.

Who gets insomnia?

Insomnia is common. It affects women more often than men. You can get it at any age, but older adults are more likely to have it. You are also at higher risk of insomnia if you

  • Have a lot of stress
  • Are Depressed or have other emotional distress, such as divorce or death of a spouse
  • Have a lower income
  • Work at night or have frequent major shifts in your work hours
  • Travel long distances with time changes
  • Have an inactive lifestyle
  • Are African American; research shows that African Americans take longer to fall asleep, don't sleep as well, and have more sleep-related breathing problems than whites.
What other problems can insomnia cause?

Insomnia can cause daytime sleepiness and a lack of energy. It also can make you feel anxious, Depressed, or irritable. You may have trouble focusing on tasks, paying attention, learning, and remembering. Insomnia also can cause other serious problems. For example, it could make you may feel drowsy while driving. This could cause you get into a car accident.

How is insomnia diagnosed?

To diagnose insomnia, your health care provider

  • Takes your medical history
  • Asks for your sleep history. Your provider will ask you for details about your sleep habits.
  • Does a physical exam, to rule out other medical problems that might cause insomnia
  • May recommend a sleep study. A sleep study measures how well you sleep and how your body responds to sleep problems.
What are the treatments for insomnia?

Treatments include lifestyle changes, counseling, and medicines:

  • Lifestyle changes, including good sleep habits, often help relieve acute (short-term) insomnia. These changes might make it easier for you to fall asleep and stay asleep.
  • A type of counseling called cognitive-behavioral therapy (CBT) can help relieve the anxiety linked to chronic (ongoing) insomnia
  • Several medicines also can help relieve your insomnia and allow you to re-establish a regular sleep schedule

If your insomnia is the symptom or side effect of another problem, it's important to treat that problem (if possible).

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for depressed

depressed treatment research studies

Lorazepam clinical trials, surveys and public health registries


Find Drug Side Effect reports



Lorazepam Side Effects

Completed Suicide (220)
Somnolence (138)
Poisoning (137)
Suicide Attempt (121)
Overdose (105)
Anxiety (104)
Agitation (100)
Tachycardia (84)
Cardiac Arrest (81)
Confusional State (80)
Nausea (79)
Respiratory Arrest (73)
Dizziness (70)
Coma (68)
Sopor (68)
Hypotension (66)
Fall (66)
Toxicity To Various Agents (65)
Intentional Overdose (64)
Dyspnoea (61)
Fatigue (57)
Vomiting (56)
Depression (56)
Insomnia (56)
Cardio-respiratory Arrest (55)
Death (55)
Sedation (52)
Headache (49)
Loss Of Consciousness (48)
Asthenia (45)
Convulsion (45)
Diarrhoea (43)
Metabolic Acidosis (42)
Condition Aggravated (39)
Tremor (37)
Pyrexia (34)
Product Substitution Issue (34)
Unresponsive To Stimuli (34)
Suicidal Ideation (33)
Psychotic Disorder (33)
Feeling Abnormal (33)
Catatonia (33)
Pain (33)
Gait Disturbance (32)
Disorientation (31)
Respiratory Failure (31)
Syncope (30)
Malaise (30)
Depressed Level Of Consciousness (29)
Oxygen Saturation Decreased (29)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Feeling apathetic, lack of interest in anything. Not sure if it is my emotional state or because of lorazepam

Hi, i was on loraezpam for anxiety attacks and was having some side affects off of it and stopped taking it.i was taking it for about a month or less. it made me feel more depressed then i was. how long does it take to get out of the system?

Im 20 and around for months ago i become serverly depressed due to stress and anxiety .so my doctor put me on 15mg martazipine to get me out and help with my depression . but the only big problem is i feel emotionaly numb and i dont recognise myself

hi I have long use Leponex Clozapine (25 mg three times) my diagnosis F20.1 that would have some consequences that already 11 years receive I think it was not anything my doctor gave me the wrong diagnosis because that day was a bit depressed I wen

Thankyou for witing out this article I have been on 120mgs of Zeldox since November 2010 at first it seemed to work and now it has me stuck in a depression state . I was prior to that on olanzapine which held me also in a depressed state I

hi there, could you help me with this, if you have experienced with Ventolin My sister felt so useless and depressed, so she took her<span style='color: #366388;'>ventolin inhalerand&

<strong></strong><span style='color: #808080;'>i took zopiclone becaouse i coulnd sleep ... but i felt depressed, i had bad feeling in my chest, my blood pressurewas too fast, sometimeswas difficult to breath for

<strong>Constipation, Fluid build up under my eyes, Depressed</strong>

57 year old female,been on Warfarin for about three years due to repeated DVT. I have been depressed for a few years also, Taking Citolopram for that. Wondering if anyone has experienced fatique while on Warfarin. Even when I am f

After being on cipralex for one week, I started feeling more depressed, extreem hunger, irritable, panic attacks and tired. My doctor told me that the medican would take 5 weeks before I felt effects from it. On week two I experienced a sev

After one dose of 50mg felteuphoric, dizzy,out of touch with reality and extremely depressed; unable to functionas normal.great for pain but don't think I can continue withthis.

Am so pleased i gave up on champix last nov , but got very depressed and nasty to family and friends !! it is still going on and my weight is increasing by the week even though i go to the gym 5 times a week,its not natural am obsessed by my figure a

Bad!!!! Very weak physically, pain in joints, very depressed, brain fog, over sleeping, tremendous weight gain, loss of interest in life.

Depressed Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Depression Management at the Workplace
Condition: Depression
Interventions: Other: Depression Product Detailing;   Other: Depression HEDIS detailing
Outcome Measures: employer purchase of depression management product;   fidelity of depression management model purchased to evidence-based models
2 Recruiting Evaluation of a Stepped Care Approach to Manage Depression in Diabetes
Conditions: Major Depressive Disorder;   Minor Depressive Disorder;   Sub-Threshold Depression;   Diabetes Mellitus
Interventions: Behavioral: Step 1: Diabetes-Specific CBT (5 group sessions);   Behavioral: Step 2: Depression-Specific CBT (6 single sessions);   Behavioral: Step 3: Referral to Psychotherapist and/or Psychiatrist;   Behavioral: Standard Diabetes Education
Outcome Measures: Depressive Mood - Hamilton Rating Scale for Depression (HAMD);   Diabetes-Related Distress - The Problem Areas in Diabetes Questionnaire (PAID);   Psychological/ Emotional Well-Being - The WHO-5 Well-being Index (WHO-5);   Health-Related Quality of Life - The Short Form-36 Health Survey (SF-36);   Diabetes Self-Care Behavior - The Summary of Diabetes Self-Care Activities Measure (SDSCA);   Glycaemic Control (HbA1c);   Health-Related Quality of Life - The EuroQol-5D (EQ-5D);   Diabetes Self-Care Behavior - The Diabetes Self-Management Questionnaire (DSMQ)
3 Recruiting New Clinical Applications for Internet-based Cognitive Behavior Therapy for Insomnia and Depression
Conditions: Insomnia;   Major Depression;   Minor Depression
Interventions: Behavioral: Therapist guided Internet-CBT for insomnia w. extra support;   Behavioral: Therapist guided Internet-CBT for insomnia;   Behavioral: Therapist guided Internet-CBT for insomnia and depression;   Behavioral: Therapist Guided Internet-CBT for depression plus insomnia placebo
Outcome Measures: Change (from baseline) in Insomnia Severity Index (ISI);   Change (from baseline) in Montgomery Asberg Depression Rating Scale, MADRS-S;   Change (from baseline) in Sleep Diary;   Changes (from baseline) in Actigraph data;   Change (from baseline) in Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P);   Change (from baseline) in Cognitive functioning;   Change (from baseline) in EuroQuol. EQ-5D;   Change (from baseline) in Sheehan Disability Scale;   Change (from baseline) in Clinical Outcome in Routine Evaluation - 10, CORE-OM
4 Recruiting Psychological Mindedness as a Predictor of Success in Cognitive Behavior Therapy for Depression
Conditions: Major Depressive Disorder;   Dysthymia
Intervention: Behavioral: Cognitive Behavior Therapy for Depression
Outcome Measure: Level of depression as measured by the Hamilton Rating Scale for Depression
5 Recruiting Study of Web- Based Cognitive Behavioral Therapy for Depressed Korean Adolescents
Conditions: Depression;   Mental Disorder in Adolescence;   Cognitive Behavioral Therapy
Interventions: Behavioral: web-based CBT;   Behavioral: supportive care
Outcome Measures: The Center for Epidemiological Studies of Depression (CES-D) Scale;   Subjective Depressed mood scale;   The Korean youth self report (K-YSR);   Acceptability and adherence of Web-based cognitive behavioral treatment program for adolescents with depression;   satisfaction of Web-based cognitive behavioral treatment program of both adolescents with depression and their parents;   Columbia suicide severity rating scale;   Adolescent's characteristics that moderate the impact of the program
6 Unknown  Low Intensity Versus Self-guided Internet-delivered Psychotherapy for Major Depression
Condition: Depression
Interventions: Other: Low Intensity Internet-delivered psychotherapy;   Other: Self-guided Internet delivered psychotherapy;   Other: Improved treatment as usual
Outcome Measures: Severity of depressive symptomatology measured by Beck Depression Inventory II;   Socio-demographic variables.;   Mini-International Neuropsychiatric Interview (MINI).;   EuroQoL-5D questionnaire (EQ-5D - Spanish version);   Client Service Receipt Inventory - adapted (CSRI - Spanish version);   Overall Depression Severity and Impairment Scale;   Positive and Negative Affect Scale (PANAS);   Credibility/expectancy questionnaire
7 Recruiting Prevalence Study of Depression in Chinese Patients With Type 2 Diabetes (HK13)
Conditions: Diabetes;   Depression
Interventions: Other: Psychiatrist Interview;   Other: Depression screening - control
Outcome Measures: Depression and psychological well-being;   Percentage of patients who attain 2 or more of the 'ABC' targets;   Self care and Efficacy;   Quality of life
8 Unknown  Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression
Conditions: Bipolar Disorder;   Bipolar Depression;   Bipolar I Depression;   Bipolar II Depression
Intervention: Drug: Minocycline
Outcome Measures: Change from baseline to week 8 on the Montgomery Asberg Depression Rating Scale (MADRS);   Change from baseline to week 8 on the Hamilton Depression Rating Scale 17-item (HAMD-17);   Change from baseline to week 8 on the Somatic Symptom Inventory (SSI);   Change from baseline to week 8 on the Clinical Global Impression (CGI) Rating Scale;   Change from baseline to week 8 in the in neurocognitive function;   Monitoring of Side-effects from baseline to week 8 with the Toronto Side Effect Scale (TSES);   Monitoring of suicide severity from baseline to week 8 with the Columbia Suicide Severity Rating Scale (C-SSRS).;   Change from baseline to week 8 in concentrations of pro-and anti-inflammatory cytokines (i.e. TNFα, IL-1β, IL-2, IL-6, IL8, IFNγ, IL-4, IL-5, IL-10)
9 Recruiting Determining Relationships Among Maternity Stress & Sleep
Conditions: Postpartum Depression;   Depression
Intervention:
Outcome Measures: Feasibility of the study protocol during the prenatal phase. Feasibility will be defined by the successful completion of enrollment and stress testing lab visits in 13 out of the 15 participants designed per group.;   Feasibility with respect to the ability to retain participants / avoid attrition, which will be defined as having at least 90% of participants who completed the prenatal phase of the study, also complete one of the postpartum phone interviews.;   The investigators will test for group differences, between women with or without depression histories, in stress reactivity of cortisol [calculated using area under the curve (AUC)] to a mild psychosocial stressor paradigm.;   The investigators will test for group differences, between women with or without depression histories, in stress reactivity of adrenocorticotropic hormone ACTH [calculated using area under the curve (AUC)] to a mild psychosocial stressor paradigm.;   The investigators will use a two-group t-test, or a Mann-Whitney-Wilcoxon test for non-normal distributions, to test for group differences in prenatal depressive symptoms using the Endinburgh Postnatal Depression Scale (EPDS).;   The investigators will use a two-group t-test, or a Mann-Whitney-Wilcoxon test for non-normal distributions, to test for group differences in prenatal anxious symptoms using the Spielberger State-Trait Anxiety Inventory (STAI), trait version.;   The investigators will use a two-group t-test, or a Mann-Whitney-Wilcoxon test for non-normal distributions, to test for group differences in recent stressful life events (last 6 months) using the Life Events Scale (LES).;   The investigators will use a two-group t-test, or a Mann-Whitney-Wilcoxon test for non-normal distributions, to test for group differences in prenatal sleep quality (past 30 days) using the Pittsburgh Sleep Quality Index (PSQI).
10 Not yet recruiting Blended Collaborative Care for Heart Failure and Co-Morbid Depression
Conditions: Heart Failure, Systolic;   Depression;   Cardiovascular Disease
Interventions: Behavioral: Collaborative Care for Heart Failure;   Behavioral: Collaborative Care for Depression
Outcome Measures: Medical Outcomes Study (MOS) 12-Item Short Form Health Survey Mental Component Summary (SF-12 MCS);   Kansas City Cardiomyopathy Questionnaire (KCCQ-12);   Hamilton Rating Scale for Depression (17-Item);   Incidence of Rehospitalization;   Mortality;   Health Care Costs;   Employment
11 Unknown  Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale
Condition: Depression, Postpartum
Intervention: Procedure: Edinburgh Postnatal Depression Scale
Outcome Measures: Mother's mental health at 6 months postpartum, as measured on the EPDS and General Health Questionnaire-12 (GHQ-12), both being self-report questionnaires.;   Mother's parenting stress (measured by the Parenting Stress Index, a self-report questionnaire);   Marital relationship satisfaction (measured by the Chinese Kansas Marital Satisfaction Scale, a self-report questionnaire);   Marital status and employment status (both father and mother, where applicable) at 6 and 18 months postpartum;   Child health measures, including weight at 6 and 18 months, number of hospitalizations and visits to doctors within the first 6 and 18 months as reported by mother;   Mother's mental health outcome (EPDS and GHQ scores) at 18 months postpartum
12 Unknown  Changing Minds - Supporting Depressed Elderly People With an Individually Tailored Service Model
Conditions: Depression;   Psychological Well-Being
Intervention: Behavioral: Comprehensive psychosocial support for Depressed elderly
Outcome Measures: Alleviating depressive symptoms measured with Geriatric Depression Scale;   Quality of life measured with WHO QuolBref
13 Recruiting Ecosystem Focused Therapy for Treating Older Depressed Stroke Survivors
Conditions: Ischemic Stroke;   Depression
Interventions: Behavioral: Ecosystem Focused Therapy (EFT);   Behavioral: Education in stroke and depression
Outcome Measures: Depression;   Disability
14 Recruiting PRimary Prevention Of Depression in Offspring of Depressed Parents
Condition: Depression
Intervention: Behavioral: Prevention programme
Outcome Measures: Presence or absence of a depressive episode (child);   Symptoms of depression (child);   Psychopathological symptoms (child)
15 Not yet recruiting Effects of Repeated Attachment Security Priming on Depressed Mood: a Clinical Study
Condition: Unipolar Depression
Intervention: Other: Attachment security priming
Outcome Measures: Depressed Mood 1;   Felt Security 1;   Depressed Mood 2;   Depressed Mood 3;   Felt Security 2;   Felt Security 3
16 Not yet recruiting A Family-based Primary Care Intervention to Enhance Older Men's Depression Care
Condition: Major Depression
Interventions: Behavioral: Family-based depression intervention;   Behavioral: Usual care plus educational materials
Outcome Measures: Depressive symptoms;   Medication adherence;   Family caregiver satisfaction;   Health-related functional disability;   Family self-management support
17 Unknown  Trial for Postnatal Depression
Conditions: Postnatal Depression;   Depression, Postpartum
Intervention: Behavioral: Complex Intervention
Outcome Measures: Hamilton Depression Rating Scale (HDRS);   Edinburgh Postnatal Depression Scale (EPDS);   Infants' weight;   Infants' height;   OSLO 3-Items Social Support Scale;   EuroQol-5D(EQ-5 D);   Maternal Attachment Inventory (MAI)
18 Recruiting Management of Depression in Primary Care
Condition: Depression
Intervention: Behavioral: Structured patient-centered follow up of depression
Outcome Measures: Change in Depressive symptoms;   Change in Quality of life;   Prescriptions for antidepressants;   Change in Activity/work ability;   sick-listing data
19 Recruiting Home-delivered Intervention for Depressed, Cognitively Impaired Elders
Conditions: Depression;   Dementia;   Geriatrics
Interventions: Behavioral: Problem Adaptation Therapy (PATH);   Behavioral: Supportive Therapy
Outcome Measures: Depression;   Disability
20 Not yet recruiting Healthy Moms-Healthy Kids: Reducing Maternal Depression for Better Outcomes in Head Start Children
Conditions: Maternal Depression;   Parenting Behavior;   Health;   Interpersonal Relationships;   Goal Directed Behavior,;   Child Behavior;   Child School Readiness
Intervention: Behavioral: Interpersonal Psychotherapy for Depression -Group
Outcome Measure: Beck Depression Inventory